Date of Award

Spring 5-17-2025

Embargo Period

5-12-2025

Document Type

Dissertation

Degree Name

Doctor of Health Administration

Department

Health Administration

College

College of Health Professions

First Advisor

Kit N. Simpson

Second Advisor

Veronica Deas

Third Advisor

Caitlin Koob

Abstract

The increasing interest in glucagon-like peptide-1 (GLP-1) agonists, such as semaglutide, which are often prescribed as a first-line treatment for managing Type II diabetes, as well as for non-diabetic purposes—such as weight management and improving metabolic health—highlights their potential in preventive care. This promise inspires hope for a future where preventive healthcare is more effective and accessible to a wider audience. Nonetheless, significant geographic disparities in access to healthcare, especially between rural and urban areas, create obstacles that prevent numerous patients from reaping the benefits of these essential medications. In rural communities, challenges like cost, availability, and awareness are often more severe, which leaves many without the critical treatment they need. This study uses a quantitative, comparative design to examine disparities in GLP-1 agonist access among patients with obesity in rural and urban communities. It analyzes secondary data, sourced from the MarketScan database, is analyzed to explore access patterns related to GLP-1 agonists. The objective is to identify gaps in medication access for populations utilizing these treatments for preventive and non-diabetic purposes. This research will guide the development of targeted interventions that significantly influence healthcare policy, including policy changes to lower costs, improve provider education, and enhance medication availability in underserved areas. The ultimate goal is to develop strategies that ensure equitable healthcare access, allowing all individuals to benefit from the preventive advantages of GLP-1 agonists.

Rights

Copyright is held by the author. All rights reserved.

Download

Share

COinS